Wearable hearing support that looks like ordinary glasses is moving from prototype toward the high street. Legato has emerged from stealth with $12 million to build Legato Frames, its eyewear with hearing‑assistance technology tucked into the frame arms, the company told TechCrunch. Legato Frames are expected to ship to consumers later this year.
The startup says the new capital has been focused first on getting the product right and second on telling potential customers about it: the funding has "largely gone toward product development, along with marketing efforts," the company said. Technically, Legato describes an acoustic system, signal‑processing stack and mechanical architecture that keep the frames small and lightweight while using AI to separate voice from background noise so conversations sound clearer.
Investors backing the debut round include Neotribe Ventures, Listen and Village Global. The company was co‑founded by Mehul Trivedi and Steve Romine, who built consumer wearables and hearing products at Bose and later worked on smart eyewear and hearing care at EssilorLuxottica and Audicus respectively. Legato positions the frames at people with mild to moderate hearing loss, a segment the company says is both large and under‑treated: about 50 million adults in the United States have hearing loss, and only around 20% of those diagnosed seek treatment, the company noted.
The product claims include an open‑ear dual‑speaker system that directs audio to the wearer while cancelling escaping sound, reducing leakage by reducing sound by 99% a few inches from the ear, and an AI pipeline that amplifies voices rather than simply using directional microphones. "Our goal is to make hearing as ubiquitous as vision," Legato's Mehul Trivedi said.
Legato plans to launch later this fall, selling through select eye‑care providers and online; the company says the frames will cost "a fraction" of traditional hearing aids and may be eligible for vision insurance when bought through a clinic. The immediate milestone is that retail rollout: getting the frames into clinics and in front of everyday wearers so the product faces real acoustic environments, not just lab tests.
For people with mild to moderate hearing loss the crucial question is practical: do the glasses make speech clearer in noisy, real‑world settings at a materially lower price and with the convenience of ordinary eyewear. If they do, wider adoption is plausible; if they do not, the frames will be another tidy prototype that never replaces the hard economics and clinical evidence that drive hearing‑care decisions.
